Patents by Inventor Damon Asher

Damon Asher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10066213
    Abstract: The invention relates to a process for increasing the observed titer of a virus stock for the purpose of increasing the calculated log reduction (LRV) in virus clearance studies. A tissue culture or assay plate is seeded with an indicator cell line and titrated with a virus stock followed, by a centrifugation step for about 5 minutes to about 24 hours at a g-force ranging from about 50×g to about 2400×g, and at a temperature from about 4° C. to about 39° C. The resulting calculated virus titer after undergoing the centrifugation step is 10-fold higher than the virus titer would be if determined in the absence of the centrifuging step.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: September 4, 2018
    Assignee: EMD Millipore Corporation
    Inventors: Damon Asher, Anne Leahy
  • Patent number: 9910041
    Abstract: The present invention provides methods for determining whether activated carbon can be used for removing viruses or a certain virus from a sample containing a target protein.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: March 6, 2018
    Assignee: EMD Millipore Corporation
    Inventors: Matthew T. Stone, Ushma Mehta, Damon Asher, Patricia Greenhalgh
  • Publication number: 20160123981
    Abstract: The present invention provides methods for determining whether activated carbon can be used for removing viruses or a certain virus from a sample containing a target protein.
    Type: Application
    Filed: April 4, 2014
    Publication date: May 5, 2016
    Applicant: EMD MILLIPORE CORPORATION
    Inventors: Matthew T. STONE, Ushma MEHTA, Damon ASHER, Patricia GREENHALGH
  • Publication number: 20150166965
    Abstract: The invention relates to a process for increasing the observed titer of a virus stock for the purpose of increasing the calculated log reduction (LRV) in virus clearance studies. A tissue culture or assay plate is seeded with an indicator cell line and titrated with a virus stock followed, by a centrifugation step for about 5 minutes to about 24 hours at a g-force ranging from about 50×g to about 2400×g, and at a temperature from about 4° C. to about 39° C. The resulting calculated virus titer after undergoing the centrifugation step is 10-fold higher than the virus titer would be if determined in the absence of the centrifuging step.
    Type: Application
    Filed: March 13, 2013
    Publication date: June 18, 2015
    Inventors: Damon Asher, Anne Leahy
  • Publication number: 20060018912
    Abstract: The present invention provides a snare molecules comprising an attachment moiety (which facilitates attachment of a receptor to a cell) and a receptor for a toxic pathogenic or infectious agent, e.g., a virus.
    Type: Application
    Filed: May 27, 2005
    Publication date: January 26, 2006
    Applicant: UNIVERSITY OF MASSACHUSETTS
    Inventors: Robert Finberg, Damon Asher